Status:
COMPLETED
Time Schedules for Sending Invitations to Colonoscopy Screening
Lead Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborating Sponsors:
National Center for Research and Development, Poland
Conditions:
Colorectal Cancer
Eligibility:
All Genders
55-64 years
Phase:
NA
Brief Summary
The attendance rate to population based primary screening colonoscopy within NordICC trial (The Nordic-European Initiative on Colorectal Cancer, NCT00883792) in Poland is roughly 33%. The aim of this ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Individuals aged 55-64 years living in Warsaw area randomly drawn from Population Registry and randomized to the screening arm of the NordICC trial.
- Exclusion criteria:
- Resident abroad
- Return of unopened letter of invitation and/or reminder (address unknown)
- Message from neighbour/family/post office on death of screenee (not updated in Population Registry).
- Exclusion criteria for colonoscopy:
- Individuals with previous colorectal surgery (resections, enterostomies)
- Individuals in need of long-lasting attention and nursing services (somatic or psychosocial, mental retardation).
- On-going cytotoxic treatment or radiotherapy for malignant disease
- Severe chronic (longer than trial duration) cardiac (NYHA III-IV)or lung disease
- Lifelong anticoagulant therapy with Warfarin
- A coronary event requiring hospitalization during the last 3 months
- A cerebrovascular event during the last 3 months
Exclusion
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT01505972
Start Date
March 1 2011
End Date
September 1 2011
Last Update
January 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Oncology Institute and the Maria Sklodowska-Curie
Warsaw, W.K.Roentgena, Poland, 02-781